title: Small molecule scavenger receptor BI antagonists are potent HCV entry inhibitors.
authors.affiliation: iTherX Pharmaceuticals, Inc., San Diego, CA 92191-0530, USA.
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Syder
authors.forename: Haekyung
authors.initials: H
authors.lastname: Lee
authors.forename: Mirjam B
authors.initials: MB
authors.lastname: Zeisel
authors.forename: Joe
authors.initials: J
authors.lastname: Grove
authors.forename: Eric
authors.initials: E
authors.lastname: Soulier
authors.forename: James
authors.initials: J
authors.lastname: Macdonald
authors.forename: Stephine
authors.initials: S
authors.lastname: Chow
authors.forename: Julia
authors.initials: J
authors.lastname: Chang
authors.forename: Thomas F
authors.initials: TF
authors.lastname: Baumert
authors.forename: Jane A
authors.initials: JA
authors.lastname: McKeating
authors.forename: Jeffrey
authors.initials: J
authors.lastname: McKelvy
authors.forename: Flossie
authors.initials: F
authors.lastname: Wong-Staal